Nomura Holdings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Nomura Holdings’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,623	Closed	-$463K	–	1703
2017 Q1	$463K	Buy	+4,623	New	+$494K	﹤0.01%	944
2015 Q4	–	Sell	-213	Closed	-$18K	–	2227
2015 Q3	$18K	Sell	213 -9,853	-98%	-$1.04M	﹤0.01%	1590
2015 Q2	$1.1M	Buy	+10,066	New	+$1.06M	﹤0.01%	1019

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Nomura Holdings's CBPO Position: Q2 2017 in Review

Nomura Holdings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 4,623 shares — an estimated $463K sold.

Nomura Holdings first reported a position in CBPO in Q2 2015 and held it in 3 quarters. The position peaked at $1.1M in Q2 2015. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Nomura Holdings reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Nomura Holdings sold 4,623 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $463K.
Nomura Holdings first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 3 quarters.
Nomura Holdings's China Biologic Products Holdings, Inc. position peaked at $1.1M in Q2 2015.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Nomura Holdings's 13F filing for Q2 2017, filed 15 Aug 2017.